MS Drug Takes a Feisty Approach Aimed at Younger Patients
Posted: Wed Apr 03, 2013 11:52 pm
An MS Drug Takes a Feisty Approach Aimed at Younger Patients
The Swiss drug maker Novartis is taking a sassy new tack to win converts to its oral multiple sclerosis treatment, Gilenya. Its “Hey MS, Take This!” campaign shows patients sticking out their tongues with Gilenya capsules on them to show their willingness to fight back against the neurological condition..... Read More - http://www.ms-uk.org/index.cfm/MSnews
The Swiss drug maker Novartis is taking a sassy new tack to win converts to its oral multiple sclerosis treatment, Gilenya. Its “Hey MS, Take This!” campaign shows patients sticking out their tongues with Gilenya capsules on them to show their willingness to fight back against the neurological condition..... Read More - http://www.ms-uk.org/index.cfm/MSnews